These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 16415718
1. An open-label trial of adjunctive oxcarbazepine for bipolar disorder. Conway CR, Chibnall JT, Nelson LA, McGuire JM, Abraham PF, Baram VY, Grossberg GT, Carroll BJ. J Clin Psychopharmacol; 2006 Feb; 26(1):95-7. PubMed ID: 16415718 [No Abstract] [Full Text] [Related]
2. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder. Suppes T, Kelly DI, Hynan LS, Snow DE, Sureddi S, Foster B, Curley E. Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731 [Abstract] [Full Text] [Related]
4. Oxcarbazepine in a carbamazepine-intolerant patient with bipolar affective disorder: a case report. Kalra H, Dalal PK, Allet L, Janca A. Psychiatr Danub; 2006 Jun; 18(1-2):90-1. PubMed ID: 16804505 [No Abstract] [Full Text] [Related]
5. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Hummel B, Walden J, Stampfer R, Dittmann S, Amann B, Sterr A, Schaefer M, Frye MA, Grunze H. Bipolar Disord; 2002 Dec; 4(6):412-7. PubMed ID: 12519102 [Abstract] [Full Text] [Related]
6. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. Benedetti A, Lattanzi L, Pini S, Musetti L, Dell'Osso L, Cassano GB. J Affect Disord; 2004 Apr; 79(1-3):273-7. PubMed ID: 15023507 [Abstract] [Full Text] [Related]
7. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder. Vieta E, Cruz N, García-Campayo J, de Arce R, Manuel Crespo J, Vallès V, Pérez-Blanco J, Roca E, Manuel Olivares J, Moríñigo A, Fernández-Villamor R, Comes M. Int J Neuropsychopharmacol; 2008 Jun; 11(4):445-52. PubMed ID: 18346292 [Abstract] [Full Text] [Related]
8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial. Juruena MF, Ottoni GL, Machado-Vieira R, Carneiro RM, Weingarthner N, Marquardt AR, Fleig SS, Broilo L, Busnello EA. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb 01; 33(1):94-9. PubMed ID: 19007842 [Abstract] [Full Text] [Related]
9. Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study. Kakkar AK, Rehan HS, Unni KE, Gupta NK, Chopra D, Kataria D. Eur Psychiatry; 2009 Apr 01; 24(3):178-82. PubMed ID: 19324530 [Abstract] [Full Text] [Related]
10. Treatment of bipolar depression with carbamazepine: results of an open study. Dilsaver SC, Swann SC, Chen YW, Shoaib A, Joe B, Krajewski KJ, Gruber N, Tsai Y. Biol Psychiatry; 1996 Nov 01; 40(9):935-7. PubMed ID: 8896785 [No Abstract] [Full Text] [Related]
11. Anticonvulsants in the treatment of bipolar mania. Goodnick PJ. Expert Opin Pharmacother; 2006 Mar 01; 7(4):401-10. PubMed ID: 16503812 [Abstract] [Full Text] [Related]
12. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Hirschfeld RM, Kasper S. Int J Neuropsychopharmacol; 2004 Dec 01; 7(4):507-22. PubMed ID: 15458610 [Abstract] [Full Text] [Related]
13. The use of levetiracetam to decrease mania in elderly bipolar patients. Kyomen HH. Am J Geriatr Psychiatry; 2006 Nov 01; 14(11):985. PubMed ID: 17068322 [No Abstract] [Full Text] [Related]
14. Oxcarbazepine for acute affective episodes in bipolar disorder. Vasudev A, Macritchie K, Vasudev K, Watson S, Geddes J, Young AH. Cochrane Database Syst Rev; 2011 Dec 07; (12):CD004857. PubMed ID: 22161387 [Abstract] [Full Text] [Related]
15. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Centorrino F, Albert MJ, Berry JM, Kelleher JP, Fellman V, Line G, Koukopoulos AE, Kidwell JE, Fogarty KV, Baldessarini RJ. Bipolar Disord; 2003 Oct 07; 5(5):370-4. PubMed ID: 14525559 [Abstract] [Full Text] [Related]
16. Efficacy and safety of oxcarbazepine in bipolar disorder. Mazza M, Bria P, Mazza S. Can J Psychiatry; 2007 Apr 07; 52(4):272; author reply 272-3. PubMed ID: 17500309 [No Abstract] [Full Text] [Related]
17. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders. Raja M, Azzoni A. Int J Neuropsychopharmacol; 2003 Dec 07; 6(4):409-14. PubMed ID: 14604456 [Abstract] [Full Text] [Related]
18. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Wagner KD, Kowatch RA, Emslie GJ, Findling RL, Wilens TE, McCague K, D'Souza J, Wamil A, Lehman RB, Berv D, Linden D. Am J Psychiatry; 2006 Jul 07; 163(7):1179-86. PubMed ID: 16816222 [Abstract] [Full Text] [Related]
19. Flying almost blind. Leibenluft E. Am J Psychiatry; 2006 Jul 07; 163(7):1129-31. PubMed ID: 16816212 [No Abstract] [Full Text] [Related]
20. [Comparative efficacy and tolerability of carbamazepine and oxcarbazepine during long therapy of patients with bipolar and schizoaffective disorders]. Mosolov SN, Kostiukova EG, Ladyzhenskiĭ MIa. Zh Nevrol Psikhiatr Im S S Korsakova; 2009 Jul 07; 109(10):36-41. PubMed ID: 20037568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]